News Releases

The Hospital of the University of Pennsylvania (HUP) and Penn Presbyterian Medical Center (PPMC) rank #16 in the United States and #61 globally on Newsweek’s “World’s Best Hospitals 2021,” which ranks 2,000 hospitals in over 25 countries based on their consistent excellence, distinguished physicians, top-notch nursing care and state-of-the-art technology.

Penn Medicine and Mercy Catholic Medical Center – Mercy Philadelphia Campus will come together again Saturday with a coalition of religious and community leaders from West Philadelphia to hold a mass COVID-19 vaccination clinic for 1,500 members of the local community.

Taking the first deep dive into how the immune system is behaving in patients with multisystem inflammatory syndrome in children (MIS-C), researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have found that children with this condition have highly activated immune systems that, in many ways, are more similar to those of adults with severe COVID-19.

Penn Medicine’s OncoLink — the first cancer information website on the internet — has hit a new milestone: 100,000 cancer survivors from around the world have now received a personalized survivorship care plan through the website to guide them through life after cancer.

In a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania, researchers found that Pennsylvania’s financial incentive policy encouraged hospitals to enact rapid system and practice changes to support treatment for opioid use disorder for patients visiting the ED.

Even though the use of rhythm control strategies for treating Paroxysmal Atrial Fibrillation (AF), a common abnormal heart rhythm, have increased overall in the United States, patients from racial and ethnic minority groups and those with lower income were less likely to receive rhythm control treatment - often the preferred treatment - according to new research from the Perelman School of Medicine at the University of Pennsylvania.

“One of the most exciting implications of our study is that the cilium may represent a common therapeutic target since it appears to be involved in a number of complex diseases,” said the study’s lead author, Theodore Drivas, MD, PhD, a postdoctoral fellow and clinical associate in Internal Medicine.

A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40 percent of American adults, the findings could have a major impact on weight management in primary care and other settings.

Using the immunosuppressant medication methotrexate to treat psoriasis and psoriatic arthritis is more likely to lead to serious liver complications than using the same medication to treat rheumatoid arthritis, according to research from the Perelman School of Medicine at the University of Pennsylvania.

A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen receptor (CAR) T cell therapy Kymriah™, researchers in Penn’s Abramson Cancer Center reported today in the New England Journal of Medicine.